AGEN
Price
$2.92
Change
+$0.07 (+2.46%)
Updated
Feb 13 closing price
Capitalization
105.71M
Intraday BUY SELL Signals
CRBU
Price
$1.58
Change
+$0.06 (+3.95%)
Updated
Feb 13 closing price
Capitalization
148.61M
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AGEN vs CRBU

Header iconAGEN vs CRBU Comparison
Open Charts AGEN vs CRBUBanner chart's image
Agenus
Price$2.92
Change+$0.07 (+2.46%)
Volume$280.69K
Capitalization105.71M
Caribou Biosciences
Price$1.58
Change+$0.06 (+3.95%)
Volume$1.52M
Capitalization148.61M
AGEN vs CRBU Comparison Chart in %
View a ticker or compare two or three
VS
AGEN vs. CRBU commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Hold and CRBU is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (AGEN: $2.92 vs. CRBU: $1.58)
Brand notoriety: AGEN and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 38% vs. CRBU: 136%
Market capitalization -- AGEN: $105.71M vs. CRBU: $148.61M
AGEN [@Biotechnology] is valued at $105.71M. CRBU’s [@Biotechnology] market capitalization is $148.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while CRBU’s TA Score has 6 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 5 bearish.
  • CRBU’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а -0.68% price change this week, while CRBU (@Biotechnology) price change was +0.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 16, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($149M) has a higher market cap than AGEN($106M). CRBU YTD gains are higher at: -0.629 vs. AGEN (-7.006). AGEN has higher annual earnings (EBITDA): 33.3M vs. CRBU (-142.47M). CRBU has more cash in the bank: 147M vs. AGEN (3.46M). CRBU has less debt than AGEN: CRBU (25.5M) vs AGEN (45.8M). AGEN has higher revenues than CRBU: AGEN (107M) vs CRBU (9.3M).
AGENCRBUAGEN / CRBU
Capitalization106M149M71%
EBITDA33.3M-142.47M-23%
Gain YTD-7.006-0.6291,114%
P/E Ratio0.16N/A-
Revenue107M9.3M1,151%
Total Cash3.46M147M2%
Total Debt45.8M25.5M180%
FUNDAMENTALS RATINGS
AGEN: Fundamental Ratings
AGEN
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGENCRBU
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBVI32.00N/A
N/A
FCN Banc Corp
INDOY6.55N/A
N/A
Indorama Ventures Public Company Limited
NXGPF187.76N/A
N/A
Next Group Plc
KCRD0.03N/A
N/A
Kindcard Inc.
CCGFF10.12N/A
N/A
Credit Corp Group Ltd.

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with TAOX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
+2.46%
TAOX - AGEN
91%
Closely correlated
+5.91%
PALI - AGEN
81%
Closely correlated
-0.57%
BDTX - AGEN
50%
Loosely correlated
+1.37%
TCRX - AGEN
47%
Loosely correlated
-0.25%
CRBU - AGEN
45%
Loosely correlated
+3.95%
More

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+3.95%
CRSP - CRBU
68%
Closely correlated
+8.46%
NTLA - CRBU
66%
Loosely correlated
+2.15%
KRRO - CRBU
63%
Loosely correlated
-5.02%
BDTX - CRBU
62%
Loosely correlated
+1.37%
ARCT - CRBU
61%
Loosely correlated
+0.56%
More